FDA Inspection 1240407 — Bausch And Lomb, Inc
The FDA completed an inspection of Bausch And Lomb, Inc on May 24, 2024 in Bridgewater, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- May 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bridgewater, NJ (United States)
Additional details
Postmarket Adverse Drug Experience (PADE)